V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002303 | 10001511 | null | 59.1 | Curative (C) | 2016-01-01 | 2016-01-10 | GemCarbo Days 1+8 | N | N | 10430443 | GEMCARBO |
| 10002304 | 10001512 | 1.78 | 64 | Neo-adjuvant (N) | 2016-09-04 | 2016-09-05 | Docetaxel | 2 | N | 10430463 | DOCETAXEL |
| 10002305 | 10001513 | 1.68 | 78.7 | Palliative (P) | 2017-09-15 | 2017-09-19 | CARBOPLATIN | 02 | null | 10430464 | CARBOPLATIN |
| 10002306 | 10001514 | 1.54 | 63.5 | Palliative (P) | 2016-07-10 | 2016-07-10 | Docetaxel | 02 | N | 10430497 | DOCETAXEL |
| 10002307 | 10006170 | 1.78 | 79 | Palliative (P) | 2015-01-21 | 2015-01-28 | Docetaxel | 02 | N | 10430528 | DOCETAXEL |
| 10002308 | 10001515 | 1.54 | 75.5 | Palliative (P) | 2015-01-21 | 2015-02-07 | Carboplatin AUC 6 - 10 | N | N | 10430552 | CARBOPLATIN |
| 10002309 | 10001515 | 1.47 | null | Adjuvant (A) | 2016-04-28 | 2016-05-04 | FEC 100 | 2 | N | 10430552 | FEC |
| 10002310 | 10001516 | 1.61 | 58 | Adjuvant (A) | null | 2018-06-19 | FEC 100 | N | N | 10430601 | FEC |
| 10002311 | 10006172 | 1.66 | 100 | Palliative (P) | 2017-04-11 | 2017-04-18 | CARBOPLATIN + GEMCITABINE | N | N | 10430605 | GEMCARBO |
| 10002312 | 10001517 | null | 69 | Disease modification (D) | 2016-08-18 | 2016-08-22 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10430616 | BENDAMUSTINE + RITUXIMAB |
| 10002313 | 10001518 | 1.67 | null | Adjuvant (A) | 2017-08-26 | 2017-08-28 | CISPLATIN + VINORELBINE | 02 | N | 10430619 | CISPLATIN + VINORELBINE |
| 10002314 | 10006173 | 1.78 | 0 | Palliative (P) | 2019-05-16 | 2019-05-27 | Enzalutamide | N | N | 10430699 | ENZALUTAMIDE |
| 10002315 | 10006173 | 1.66 | 76.2 | Neo-adjuvant (N) | 2018-06-26 | 2018-07-03 | ECX | 2 | N | 10430699 | ECX |
| 10002316 | 10001519 | 0 | 104 | Disease modification (D) | 2018-04-11 | 2018-04-11 | Hydroxycarbamide | N | N | 10430732 | HYDROXYCARBAMIDE |
| 10002317 | 10001520 | 1.79 | 117.9 | Palliative (P) | 2014-02-27 | 2014-03-07 | ECX | N | N | 10430778 | ECX |
| 10002318 | 10006174 | 1.78 | 56.9 | Palliative (P) | 2018-11-02 | 2018-11-12 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 10430787 | GEMCITABINE |
| 10002319 | 10007969 | 1.71 | 61.4 | Palliative (P) | 2019-06-20 | 2019-07-02 | Enzalutamide | 02 | N | 10430831 | ENZALUTAMIDE |
| 10002320 | 10008757 | 1.67 | 70.35 | Palliative (P) | 2014-09-25 | 2014-09-25 | Hydroxycarbamide | N | null | 10430840 | HYDROXYCARBAMIDE |
| 10002321 | 10008757 | 1.73 | 94.2 | Disease modification (D) | 2017-09-13 | 2017-09-19 | CVP R | N | N | 10430840 | CVP R |
| 10002322 | 10001521 | 1.76 | 100 | Palliative (P) | 2016-12-20 | 2016-12-25 | Trial Unspecified | 01 | N | 10430996 | TRIAL |
| 10002323 | 10001522 | 1.71 | 85.9 | Curative (C) | 2016-01-19 | 2016-01-20 | CVP R | 02 | N | 10431015 | CVP R |
| 10002324 | 10001523 | 1.62 | 64.3 | Palliative (P) | 2013-08-10 | 2013-08-25 | EOX | N | N | 10431020 | EOX |
| 10002325 | 10001524 | 1.82 | 77.9 | Neo-adjuvant (N) | 2014-01-05 | 2014-03-10 | Trial Unspecified | 01 | N | 10431028 | TRIAL |
| 10002326 | 10001525 | null | 75 | Palliative (P) | 2018-04-09 | 2018-04-18 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10431032 | GEMCITABINE |
| 10002327 | 10006175 | 1.63 | 58.2 | Neo-adjuvant (N) | null | 2018-01-18 | ECX | N | N | 10431121 | ECX |
| 10002328 | 10007970 | 1.8 | 74.4 | Palliative (P) | 2016-11-26 | 2016-12-04 | GEMCITABINE | 2 | N | 10431126 | GEMCITABINE |
| 10002329 | 10007970 | 1.77 | 83.4 | Palliative (P) | 2018-04-11 | 2018-04-12 | Hydroxycarbamide | N | N | 10431126 | HYDROXYCARBAMIDE |
| 10002330 | 10001526 | 1.76 | 75 | Disease modification (D) | 2016-01-27 | 2016-01-27 | ECX | 02 | N | 10431154 | ECX |
| 10002331 | 10001527 | 1.68 | 68 | Neo-adjuvant (N) | 2017-04-28 | 2017-05-10 | Cisplatin + Vinorelbine (PO) | 02 | N | 10431176 | CISPLATIN + VINORELBINE |
| 10002332 | 10001528 | 1.68 | 72 | Palliative (P) | 2016-08-29 | 2016-09-20 | Carboplatin + Vinorelbine IV | 02 | N | 10431196 | CARBOPLATIN + VINORELBINE |
| 10002333 | 10001529 | 1.69 | 62 | Curative (C) | 2019-01-04 | 2019-01-27 | Trial Unspecified | 1 | Y | 10431214 | TRIAL |
| 10002334 | 10001530 | null | 57 | Palliative (P) | 2017-08-13 | 2017-08-28 | PEMBROLIZUMAB | 02 | N | 10431219 | PEMBROLIZUMAB |
| 10002335 | 10001531 | 0 | 76.3 | Palliative (P) | 2017-07-29 | 2017-07-29 | Trial Unspecified | 2 | N | 10431242 | TRIAL |
| 10002336 | 10001531 | 1.7 | 77 | Neo-adjuvant (N) | 2017-02-01 | 2017-02-09 | ECX | 02 | N | 10431242 | ECX |
| 10002337 | 10001531 | 1.66 | 0 | Palliative (P) | 2018-05-01 | 2018-05-15 | ECX | 02 | N | 10431242 | ECX |
| 10002338 | 10001532 | 1.77 | null | Palliative (P) | 2018-01-29 | 2018-02-15 | PEMBROLIZUMAB | N | N | 10431278 | PEMBROLIZUMAB |
| 10002339 | 10006177 | 1.6 | 93.3 | Palliative (P) | 2018-09-21 | 2018-10-10 | Cisplatin + Pemetrexed | 2 | null | 10431284 | CISPLATIN + PEMETREXED |
| 10002340 | 10001533 | 1.67 | 56 | Palliative (P) | 2017-05-13 | 2017-05-18 | Cisplatin + Pemetrexed | N | N | 10431329 | CISPLATIN + PEMETREXED |
| 10002341 | 10006178 | 1.67 | null | null | 2018-04-26 | 2018-05-03 | Rituximab | N | N | 10431394 | RITUXIMAB |
| 10002342 | 10006178 | 1.74 | 84 | Disease modification (D) | 2016-03-13 | 2016-03-14 | Hydroxycarbamide | N | Y | 10431394 | HYDROXYCARBAMIDE |
| 10002343 | 10001534 | 1.68 | 68.4 | Neo-adjuvant (N) | 2017-03-07 | 2017-03-20 | ECX | 02 | null | 10431413 | ECX |
| 10002344 | 10001535 | null | null | Curative (C) | 2017-01-04 | 2017-01-05 | R GCVP | N | N | 10431429 | CVP R |
| 10002345 | 10001536 | 1.55 | 68.8 | Curative (C) | 2014-08-03 | 2014-08-10 | CISPLATIN + VINORELBINE | N | N | 10431449 | CISPLATIN + VINORELBINE |
| 10002346 | 10001537 | 1.78 | 81.7 | Palliative (P) | 2017-08-16 | 2017-09-06 | Rituximab | N | Y | 10431553 | RITUXIMAB |
| 10002347 | 10001538 | 1.77 | 83.5 | Palliative (P) | 2018-03-02 | 2018-03-02 | Rituximab | 02 | N | 10431590 | RITUXIMAB |
| 10002348 | 10001539 | 1.72 | 65.5 | Curative (C) | 2019-01-04 | 2019-01-04 | Trial Unspecified | Y | N | 10431695 | TRIAL |
| 10002349 | 10001540 | 1.82 | null | Palliative (P) | 2016-08-15 | 2016-08-28 | EOX | null | N | 10431861 | EOX |
| 10002350 | 10001541 | 1.87 | 71.3 | Palliative (P) | 2015-06-11 | 2015-06-29 | Cisplatin + Pemetrexed | N | N | 10431996 | CISPLATIN + PEMETREXED |
| 10002351 | 10001542 | 1.63 | 62 | Palliative (P) | 2017-02-15 | 2017-02-21 | EOX | 02 | N | 10431999 | EOX |
| 10002352 | 10001542 | null | null | Curative (C) | 2016-05-12 | 2016-06-01 | Carboplatin + Vinorelbine Oral | N | N | 10431999 | CARBOPLATIN + VINORELBINE |